Skip to main content
Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Health service utilization in immigrants with multiple sclerosis

  • Dalia L. Rotstein ,

    Roles Formal analysis, Funding acquisition, Methodology, Supervision, Writing – original draft, Writing – review & editing

    Affiliations Department of Medicine, University of Toronto, Toronto, Ontario, Canada, St. Michael’s Hospital, Toronto, Ontario, Canada

  • Ruth Ann Marrie,

    Roles Conceptualization, Funding acquisition, Methodology, Supervision, Writing – review & editing

    Affiliation Departments of Medicine and Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada

  • Karen Tu,

    Roles Conceptualization, Funding acquisition, Methodology, Writing – review & editing

    Affiliations North York General Hospital, Toronto, Ontario, Canada, Departments of Family and Community Medicine and Institute for Health Policy and Management, University of Toronto, Toronto, Ontario, Canada, Toronto Western Hospital University Health Network, Toronto, Ontario, Canada

  • Susan E. Schultz,

    Roles Formal analysis, Writing – review & editing

    Affiliation ICES, Toronto, Ontario, Canada

  • Kinwah Fung,

    Roles Formal analysis, Writing – review & editing

    Affiliation ICES, Toronto, Ontario, Canada

  • Colleen J. Maxwell

    Roles Conceptualization, Funding acquisition, Methodology, Supervision, Writing – review & editing

    Affiliations ICES, Toronto, Ontario, Canada, Schools of Pharmacy and Public Health and Health Systems, University of Waterloo, Waterloo, ON, Canada



Access to neurology specialty care can influence outcomes in individuals with multiple sclerosis (MS), but may vary based on patient sociodemographic characteristics, including immigration status.


To compare health services utilization in the year of MS diagnosis, one year before diagnosis and two years after diagnosis in immigrants versus long-term residents in Ontario, Canada.


We identified incident cases of MS among adults aged 20–65 years by applying a validated algorithm to health administrative data in Ontario, Canada, a region with universal health insurance and comprehensive coverage. We separately assessed hospitalizations, emergency department (ED) visits, outpatient neurology visits, other outpatient specialty visits, and primary care visits. We compared rates of health service use in immigrants versus long-term residents using negative binomial regression models with generalized estimating equations adjusted for age, sex, socioeconomic status, urban/rural residence, MS diagnosis calendar year, and comorbidity burden.


From 2003 to 2014, there were 13,028 incident MS cases in Ontario, of whom 1,070 (8.2%) were immigrants. As compared to long-term residents, rates of hospitalization were similar (Adjusted rate ratio (ARR) 0.86; 95% CI: 0.73–1.01) in immigrants the year before MS diagnosis, but outpatient neurology visits (ARR 0.93; 95% CI: 0.87–0.99) were slightly less frequent. However, immigrants had higher rates of hospitalization during the diagnosis year (ARR 1.20, 95% CI: 1.04–1.39), and had greater use of outpatient neurology (ARR 1.17, 95% CI: 1.12–1.23) but fewer ED visits (ARR 0.86; 95% CI: 0.78–0.96). In the first post-diagnosis year, immigrants continued to have greater numbers of outpatient neurology visits (ARR 1.16; 95% CI: 1.10–1.23), but had fewer hospitalizations (ARR 0.79; 95% CI: 0.67–0.94).


Overall, our findings were reassuring concerning health services access for immigrants with MS in Ontario, a publicly funded health care system. However, immigrants were more likely to be hospitalized despite greater use of outpatient neurology care in the year of MS diagnosis. Reasons for this may include more severe disease presentation or lack of social support among immigrants and warrant further investigation.


Health service access and utilization are known to vary substantially with sociodemographic factors such as sex, race, immigrant status, and income level [14]. Disparities in health service utilization are reflected in divergent experiences of the health care system and outcomes [1,5]. However, health service utilization patterns have been less extensively described in the context of neurologic diseases, although one American study found that blacks were more likely to be hospitalized, and less likely to experience an ambulatory neurology visit, than whites [6]. Health service utilization patterns may be particularly relevant for multiple sclerosis (MS), a chronic inflammatory disease of the central nervous system (CNS) and one of the primary causes of disability in young adults [7]. The complex treatment landscape for MS today requires specialized neurology care and early implementation of disease-modifying therapy (DMT) to promote better long-term outcomes [7,8]. Little is known about which sociodemographic factors predict favourable health service utilization in people living with multiple sclerosis (MS). In a previous scoping review of the literature, non-white race was associated with worse access to health services for people with MS, although only 3 of 36 included studies were cohort studies [9].

A favourable pattern of health system utilization in those with established MS diagnoses would be characterized by regular outpatient neurology visits, as comprehensive MS care requires periodic monitoring of the patient’s symptoms, neurologic examination, MRI, and response to DMT. Most MS attacks can be managed on an outpatient basis when there is consistent access to a neurologist; hence fewer emergency department visits and hospitalizations would be expected under favourable conditions [10]. However, the initial symptoms or attack in MS may involve an emergency department visit to facilitate diagnostic work-up and possible treatment with corticosteroids [11]. Hospitalization is usually required only for more severe attacks, the risk of which is reduced by DMT [10]. Regular primary care visits may be appropriate if they complement rather than substitute for specialty neurology care and should be interpreted in that context [12].

There has been no previous study of the effect of immigrant status on health service utilization among people with MS, which is the focus of this study. The effect of immigrant status on health service utilization is distinct from the question of race, as health system literacy, language, and cultural factors affect immigrants’ interaction with the health care system [13]. We conducted this study in Ontario, Canada, a region that provides an ideal environment for isolating the effect of immigrant status beyond health coverage as it has one of the largest and most diverse immigrant populations globally [14]; and because residents of Ontario have access to universal health insurance without user fees. In a previous large, community-based study, immigrants reported less favourable access to health services compared to native-born individuals in both Canada and the United States, although immigrants in Canada fared relatively better than their American counterparts [1].

We aimed to compare health services utilization in immigrants versus long-term residents with incident multiple sclerosis (MS) in Ontario, Canada. We focused on utilization before, during, and after the MS diagnostic year. Identifying disparities in health service utilization in immigrants can lead to better understanding of inequities in health care outcomes and strategies to mitigate these disparities.



This retrospective cohort study was performed in the province of Ontario, Canada, using linked health administrative data. At more than 14 million residents, Ontario is the province with the largest population in Canada, and is home to the largest contingent of immigrants in Canada [15]. Billings and administrative data are collected through OHIP (the Ontario Health Insurance Plan), which is a universal, publicly funded program that covers both in-patient and out-patient physician and hospital services without user fees.

Data sources

The following datasets were linked by unique encoded identifiers and analyzed at ICES. The National Ambulatory Care Reporting System (NACRS) in Ontario captures emergency department (ED) visits, including visit date and the reason for visit, which is reported using International Classification of Disease 10th revision Canadian enhancement (ICD 10-CA) codes. The Canadian Institute for Health Information Discharge Abstract Database (CIHI-DAD) provides data on hospitalizations including dates of admission and discharge as well as diagnoses recorded using ICD-10-CA codes. We obtained demographic information from the Registered Persons Database (RPDB) of Ontario, including age, sex, health insurance eligibility, postal code of residence (used to derive neighbourhood income quintile and urban/rural residence), and death information. Outpatient physician visits were determined from physician billing claims from OHIP. Immigrant data were obtained through the electronic Permanent Resident Database of Immigration, Refugees and Citizenship Canada (IRCC), as detailed below.

Study populations


The electronic IRCC data captures all immigrants arriving in Canada since 1985. Immigrant data have been linked with OHIP data using probabilistic matching [14] and with the RPDB. We thus identified immigrants arriving in Ontario since 1985. Long-term residents were defined as individuals born in Ontario or whose first date of residence in Ontario occurred before 1985. The same approach was used in several previous studies of immigrants in Ontario [14,16].

MS cases.

Cases of MS were identified using a validated algorithm applied to health administrative billing data [17]. Briefly, the algorithm required one hospitalization or at least 5 outpatient visits for MS over a two-year period using the International Classification of Disease (ICD)-9/10-CA codes 340/G35. This algorithm has a sensitivity of approximately 85% and a specificity approaching 100% [17]. The index date was determined by the first in-patient or out-patient contact for a demyelinating condition as indicated by ICD-9/10-CA codes, including encephalomyelitis (323/G36 or G37), optic neuritis (377/H46), or MS (340/G35), in individuals who later met the MS algorithm. For hospitalizations, both primary and secondary discharge diagnoses of MS (340/G35) were included.

The year of MS diagnosis was defined as the period from six months before until 6 months after the index date (Fig 1), to account for symptoms arising weeks to months in advance of the diagnostic visit. A similar approach has been used in previous studies [18,19]. Hence, the year before MS diagnosis was defined as the year up until 6 months before the index date, and the first year following diagnosis began 6 months after the index date. The second year following diagnosis was thus defined from 1.5 years up to 2.5 years following the index date.

Fig 1. Health service utilization periods relative to MS diagnosis.

Fig 1 demonstrates the four periods of health service utilization relative to the date of MS diagnosis.

Cohort selection

Cohort selection is shown in Fig 2. Briefly, data collection began in 2003 because this was the first year when electronic data were available for all datasets. Incident MS cases were identified between 1 January 2003 and 31 December 2014. End of study for health service utilization data was up until 30 June 2017 to allow for 2.5 years of follow-up after the MS index date. OHIP eligibility of at least 2 years was required for cohort selection to ensure that we were identifying incident as opposed to prevalent cases. We included those who were ≥20 or ≤65 years of age at cohort entry. The lower limit on age was imposed because MS is rare in children and the algorithm for identifying MS cases in Ontario had not been validated for those <20 years at the time this study started [20]. The upper limit on age was chosen because of the relative rarity of new MS diagnoses and possible misdiagnosis at age >65 years [21]. Individuals who were not resident in Ontario or those who died at the time of MS diagnosis were excluded.

Fig 2. Health service utilization cohort selection flowchart.

Fig 2 illustrates selection of the study cohort of individuals diagnosed with MS.


The number of hospital admissions per person were recorded for year before MS diagnosis, year of diagnosis, and first two years following diagnosis. The number of outpatient neurology, other specialist (e.g. surgery, obstetrics, internal medicine, psychiatry, ophthalmology) and primary care visits per year were likewise recorded. We determined whether MS (340/G35) was listed as the primary diagnosis or cause of the visit for all years except for the year before MS diagnosis and for all visit types except for outpatient neurology visits, because of the potential for conflation of different indications for neurologic consultation.


Covariates included MS diagnosis year (grouped as 2003–04 (reference group), 2005–09, and 2010–14), age group at MS index date (age 20–35, 36–50, and 51–65 years; the latter was the reference group), sex, neighbourhood income quintile, urban/rural residence, and comorbidity burden. Covariates were defined as previously described [22]. Briefly, urban residence was classified by residence in any area with a population of ≥10,000 residents. Postal code of residence was linked with the nearest year of Canadian Census data to determine urban residence and neighbourhood income quintile. Comorbidity burden was measured using ACG® System Aggregated Diagnosis Groups (ADGs) Mortality Risk Score, a weighted score which incorporates ADGs and predicts 1-year mortality [23]. ADGs are based on the Johns Hopkins ACG® System Ver. 10, and are determined from hospitalization and physician visit data for the two years before the index date. Region of origin was included in the descriptive baseline characteristics of the immigrant cohort and classified as Africa, the Caribbean, East Asia, Hispanic America, the Middle East, South Asia, and Western countries (the United States, Europe, Russia, and Australia).


Baseline characteristics of immigrants versus long-term residents at MS index date were summarized using descriptive statistics. We compared the cohorts using Student’s t-tests for continuous variables and chi-square tests for categorical variables. Crude rates of number of visits per 100 person-years (with 95% confidence intervals [CI]) were calculated for hospitalizations, ED visits, outpatient neurology and outpatient primary care visits based on a negative binomial distribution. Hospital length of stay was reported in days. For hospital admissions and ED visits, we analyzed MS-specific and total number of visits separately. MS-specific visits were not considered in the year before diagnosis because by our cohort definitions there were no recorded MS indications at that time. We compared utilization rates between immigrants and long-term residents using rate ratios (RR) and 95% CI.

We then evaluated the association between immigrant status and health services utilization using negative binomial regression models, fitted via generalized estimating equations with an exchangeable correlation matrix to account for dependencies introduced by multiple measurements per individual. To account for partial residency time during a given year, we included the logarithm of person-time as an offset in all models. To identify yearly trends, an interaction term was included between immigrant status (yes or no) and the period (-1 to 2; i.e. –1 indicates 1 year before the diagnosis year) in all models. Rate ratios were adjusted for age at MS diagnosis, sex, income quintile, comorbidity burden (weighted ADG score), MS diagnosis calendar year, and urban/rural residence using the negative binomial regression models.

Model assumptions were tested using standard methods [24]. Statistical analyses were conducted using SAS version 9.4 (SAS Institute Inc., Cary, NC).

This study was approved by the research ethics boards at St. Michael’s Hospital in Toronto, Ontario, Canada. Use of Ontario data in this study was authorized under section 45 of Ontario’s Personal Health Information Protection Act. Section 45 authorizes ICES to collect personal health information, without consent, for the purpose of analysis or compiling statistical information with respect to the management of, evaluation or monitoring of, the allocation of resources to or planning for all or part of the health system.


We identified 13,755 incident MS cases in Ontario from 2003–2014; 13,028 (94.7%) qualified for inclusion (Fig 2). Among the analytical sample, 1,070 (8.2%) were immigrants. Immigrants were slightly younger at diagnosis, had overall lower socioeconomic status as represented by neighbourhood income quintile, more often lived in urban areas, had lower mean comorbidity burden, and were more likely to enter the cohort in the later years of the study (Table 1). More than 81% had been living in Canada for at least 5 years. There was no significant difference observed in sex distribution across the groups. The most highly represented regions of origin were Western countries (including Europe and North America) and the Middle East.

Table 1. Baseline characteristics of cohort comparing immigrants versus long-term residents with MS.

Health service utilization analysis

ED visits.

Immigrants had lower rates of total ED use in the year before, the year of diagnosis and for the two post-diagnosis years (Table 2 and Fig 3A). Rates of MS-specific ED visits were similar in immigrants compared to long-term residents in the year of diagnosis and the two years post-diagnosis.

Fig 3. Crude rates of health service utilization in immigrants vs. long-term residents with MS.

Crude rates of health service utilization are shown for immigrants with MS compared to long-term residents with MS for (A) Emergency Department visits, (B) hospitalizations, and (C) outpatient neurology and primary care visits. For Emergency Department visits and hospitalizations, all event and MS-specific event rates are displayed.

Table 2. Unadjusted and adjusted rate ratios comparing health services utilization in immigrants vs. long-term residents with multiple sclerosis.


Rates of hospitalization in immigrants were similar to long-term residents in the year before diagnosis (Table 2). Immigrants had higher rates of both total and MS-specific hospitalizations in the MS diagnosis year (Table 2 and Fig 3B). In contrast, total and MS-specific hospitalizations were less frequent in immigrants in the first post-diagnosis year, but not significantly different from long-term residents in the second post-diagnosis year. Hospital length of stay (days) was longer in immigrants but this difference was not statistically significant.

Primary care visits.

Primary care visits, both total and MS-specific were less frequent in immigrants from the year before MS diagnosis through two years following diagnosis (Table 2 and Fig 3C).

Neurology outpatient visits.

Immigrants had lower rates of total neurology outpatient visits in the year before diagnosis, but higher rates of neurology specialty care in the year of MS diagnosis and for the two years post-diagnosis (Table 2 and Fig 3C).

Other specialist outpatient visits.

Other specialist outpatient visits were more likely among immigrants in the year before MS diagnosis, the year of diagnosis, and the first post-diagnosis year (Table 2). In the second post diagnosis year, they continued to be more frequent in immigrants but this finding did not meet statistical significance. Similarly, MS-specific outpatient visits tended to be more common in immigrants in the year of MS diagnosis through two years following diagnosis but these observations were not statistically significant.

For most variables the regression analysis did not substantially alter the observed relationships. For the year of MS diagnosis, the relationship between immigrant status and total inpatient hospitalizations became statistically significant with adjustment for covariates; the relationship between immigrant status and MS-specific hospitalizations was statistically significant in both the adjusted and unadjusted analyses.


This novel study examined health services utilization in a large, population-based cohort of immigrants and long-term Ontario residents with MS. Immigrants demonstrated a higher rate of hospitalization in the year of MS diagnosis, despite greater use of neurology outpatient care. Other notable findings were a lower rate of primary care outpatient visits in immigrants and higher rates of other, non-neurology outpatient specialist visits. Overall, these findings suggest that immigrants with MS in Ontario, Canada, a region with universal health care insurance, are not systematically disadvantaged in their access to health services. Individuals with MS are expected to have higher rates of health services use compared to the general population, although many MS-related symptoms can be managed today on an outpatient basis [18,25,26]. In a previous scoping review of the literature, non-white race was associated with less access to health services in individuals with MS, although immigrant status was not investigated [9]. Studies of health service utilization may improve understanding of disparities across sociodemographic groups and in turn support policies to address those disparities.

However, despite the generally positive findings concerning access to health services in immigrants with MS in Ontario, the finding of a higher rate of hospitalization in the year of MS diagnosis is concerning, as higher use of outpatient neurology care is generally associated with fewer hospitalizations in neurologic diseases [6]. Possible explanations could include a more severe or sudden presentation of neurologic symptoms in immigrants with MS. More severe early demyelinating attacks and less neurologic recovery have been observed in individuals of non-white race in past research [27,28]. We previously reported a higher risk of mortality in immigrants compared to long-term residents in the year following MS onset, although mortality in immigrants was lower thereafter [22]. Alternatively, immigrants may lack health system literacy and social supports which could mitigate the consequences of a first attack or other illness. However, a previous study found that economic class immigrants to Ontario had lower overall rates of hospitalization than the general population, possibly a reflection of the healthy migrant effect [29]. Immigrants to Ontario had lower rates of hospitalization for circulatory diseases in another study [30]. We did not observe higher rates of total or MS-specific hospitalization in immigrants outside of the MS-diagnosis year, which may argue against social supports playing a prominent role in the hospitalization patterns observed.

Lower rates of use of certain health services including outpatient neurology by immigrants in the year before MS diagnosis also raise the question of whether immigrants may have a shorter or less discernible MS prodrome, with more abrupt onset of demyelinating symptoms, compared to long-term residents in Canada. The MS prodrome refers to the onset of early symptoms that precede presentation with classic symptoms of the disease, as recognized by the observation that health service utilization increases steadily in individuals with MS relative to the general population beginning five years up until the time of MS diagnosis [26,31]. Previously, a study of prodromal symptoms in women who later developed myocardial infarction found that race influenced the extent of prodromal symptoms, although the investigators did not assess immigrant status [32]. We also cannot exclude the possibility that immigrants experience similar symptoms before MS diagnosis as long-term residents but are less likely to seek out care because of financial, cultural, or language barriers and therefore may seek healthcare at later stages of the disease.

Strengths of this study include the availability of population-based continuous health services data, use of a validated algorithm for identifying MS cases [17], and the large cohort of immigrants and long-term residents with MS. We controlled for age, sex, socioeconomic status, urban/rural residence, overall comorbidity burden, and calendar year of diagnosis which may all contribute to disparities in health services use. Limitations of this study include lack of availability of prescription drug data which could have provided a more complete picture of access to needed health care resources among immigrants with MS. We cannot exclude the possibility of systematic differences in DMT prescriptions between immigrants and long-term residents but believe this is unlikely due to government coverage of DMT in Ontario for those without private drug insurance. The validated algorithm used to identify MS cases has a sensitivity of about 85%, and data concerning immigrants did not extend back before 1985, thus some MS cases may have been missed. We could not assess for differences in disability or disease severity between the immigrant and long-term resident populations because of lack of clinical data in the administrative health claims databases. Socioeconomic status was approximated by neighbourhood income quintile because individual-level variables such as household income are not collected as part of the health administrative data in Ontario. There may be some year-to-year stochastic variation in health service use. Last, this study focused on a region with universal health insurance with health services free at the point of care; health services use in immigrants with MS may differ under other insurance models and in other geographic regions.


In conclusion, immigrants with MS in Ontario, Canada demonstrated a generally favourable pattern of access to health services, with greater use of neurology outpatient care and lower use of emergency department services. However, in the year of MS diagnosis immigrants had a higher rate of both total and MS-specific hospitalizations compared to long-term residents. Reasons for this are unclear but warrant further investigation and may include a more severe or abrupt presentation of neurologic symptoms of MS in immigrants.


  1. 1. Lasser KE, Himmelstein DU, Woolhandler S. Access to care, health status, and health disparities in the United States and Canada: results of a cross-national population-based survey. Am J Public Health. 2006;96(7):1300–7. pmid:16735628
  2. 2. Keene J, Li X. Age and gender differences in health service utilization. J Public Health (Oxf). 2005;27(1):74–9.
  3. 3. Manuel JI. Racial/Ethnic and Gender Disparities in Health Care Use and Access. Health Serv Res. 2018;53(3):1407–29. pmid:28480588
  4. 4. Penning MJ, Zheng C. Income Inequities in Health Care Utilization among Adults Aged 50 and Older. Can J Aging. 2016;35(1):55–69. pmid:26757886
  5. 5. Dubay LC, Lebrun LA. Health, behavior, and health care disparities: disentangling the effects of income and race in the United States. Int J Health Serv. 2012;42(4):607–25. pmid:23367796
  6. 6. Saadi A, Himmelstein DU, Woolhandler S, Mejia NI. Racial disparities in neurologic health care access and utilization in the United States. Neurology. 2017;88(24):2268–75. pmid:28515272
  7. 7. Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391(10130):1622–36. pmid:29576504
  8. 8. Brown JWL, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A, et al. Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis. JAMA. 2019;321(2):175–87. pmid:30644981
  9. 9. Roddam H, Rog D, Janssen J, Wilson N, Cross L, Olajide O, et al. Inequalities in access to health and social care among adults with multiple sclerosis: A scoping review of the literature. Mult Scler Relat Disord. 2019;28:290–304. pmid:30641354
  10. 10. Kobelt G, Thompson A, Berg J, Gannedahl M, Eriksson J, Group MS, et al. New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler. 2017;23(8):1123–36. pmid:28273775
  11. 11. Farber R, Hannigan C, Alcauskas M, Krieger S. Emergency Department visits before the diagnosis of MS. Mult Scler Relat Disord. 2014;3(3):350–4. pmid:25876472
  12. 12. Oh J, Gagne-Brosseau MS, Guenette M, Larochelle C, Lemieux F, Menon S, et al. Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner. Can J Neurol Sci. 2018;45(3):304–12. pmid:29756588
  13. 13. Zanchetta MS, Poureslami IM. Health literacy within the reality of immigrants' culture and language. Can J Public Health. 2006;97 Suppl 2:S26–30.
  14. 14. Tu JV, Chu A, Rezai MR, Guo H, Maclagan LC, Austin PC, et al. The Incidence of Major Cardiovascular Events in Immigrants to Ontario, Canada: The CANHEART Immigrant Study. Circulation. 2015;132(16):1549–59. pmid:26324719
  15. 15. Census Profile, 2016 Census. [Internet]. [cited February 21, 2020. ]. Available from:
  16. 16. Yarnell CJ, Fu L, Manuel D, Tanuseputro P, Stukel T, Pinto R, et al. Association Between Immigrant Status and End-of-Life Care in Ontario, Canada. JAMA. 2017;318(15):1479–88. pmid:28973088
  17. 17. Widdifield J, Ivers NM, Young J, Green D, Jaakkimainen L, Butt DA, et al. Development and validation of an administrative data algorithm to estimate the disease burden and epidemiology of multiple sclerosis in Ontario, Canada. Mult Scler. 2015;21(8):1045–54. pmid:25392338
  18. 18. Marrie RA, O'Mahony J, Maxwell CJ, Ling V, Yeh EA, Arnold DL, et al. High rates of health care utilization in pediatric multiple sclerosis: A Canadian population-based study. PLoS One. 2019;14(6):e0218215. pmid:31185042
  19. 19. Marrie RA, O'Mahony J, Maxwell C, Ling V, Yeh EA, Arnold DL, et al. Increased mental health care use by mothers of children with multiple sclerosis. Neurology. 2020.
  20. 20. Krysko KM, Ivers NM, Young J, O'Connor P, Tu K. Identifying individuals with multiple sclerosis in an electronic medical record. Mult Scler. 2015;21(2):217–24. pmid:24948683
  21. 21. Bermel RA, Rae-Grant AD, Fox RJ. Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy. Mult Scler. 2010;16(11):1335–40. pmid:20670982
  22. 22. Rotstein D, Maxwell C, Tu K, Schultz SE, Fung K, Marrie RA. Risk of Mortality in Immigrants with Multiple Sclerosis in Ontario, Canada. Neuroepidemiology. 2020:1–9.
  23. 23. Austin PC, Walraven C. The mortality risk score and the ADG score: two points-based scoring systems for the Johns Hopkins aggregated diagnosis groups to predict mortality in a general adult population cohort in Ontario, Canada. Med Care. 2011;49(10):940–7. pmid:21921849
  24. 24. Armitage P BG, Matthews J. Statistical Methods in Medical Research. Oxford: Blackwell Science 2002.
  25. 25. Marrie RA, Elliott L, Marriott J, Cossoy M, Blanchard J, Tennakoon A, et al. Dramatically changing rates and reasons for hospitalization in multiple sclerosis. Neurology. 2014;83(10):929–37. pmid:25085638
  26. 26. Marrie RA, Yu N, Wei Y, Elliott L, Blanchard J. High rates of physician services utilization at least five years before multiple sclerosis diagnosis. Mult Scler. 2013;19(8):1113–9. pmid:23263898
  27. 27. Mowry EM, Pesic M, Grimes B, Deen S, Bacchetti P, Waubant E. Demyelinating events in early multiple sclerosis have inherent severity and recovery. Neurology. 2009;72(7):602–8. pmid:19221292
  28. 28. Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D. Does multiple sclerosis-associated disability differ between races? Neurology. 2006;66(8):1235–40. pmid:16636241
  29. 29. Ng E, Sanmartin C, Manuel DG. Hospitalization rates among economic immigrants to Canada. Health Rep. 2017;28(7):3–10. pmid:28722746
  30. 30. Ng E, Sanmartin C, Tu JV, Manuel DG. All-cause and circulatory disease-related hospitalization, by generation status: Evidence from linked data. Health Rep. 2015;26(10):3–9. pmid:26488822
  31. 31. Wijnands JMA, Kingwell E, Zhu F, Zhao Y, Hogg T, Stadnyk K, et al. Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study. Lancet Neurol. 2017;16(6):445–51. pmid:28434855
  32. 32. McSweeney JC, O'Sullivan P, Cleves MA, Lefler LL, Cody M, Moser DK, et al. Racial differences in women's prodromal and acute symptoms of myocardial infarction. Am J Crit Care. 2010;19(1):63–73. pmid:20045850